Fertility clinics are offering young mitochondria in controversial fertility technique
By Edward Chen,
Nature
| 07. 28. 2026
A small number of fertility clinics around the world are offering a controversial treatment: a procedure to furnish clients’ embryos with donated mitochondria as a way to increase the chances of taking home a baby.
The method, called mitochondrial replacement therapy (MRT), involves removing the nucleus from a person’s egg or a couple’s single-cell embryo and transplanting it into an egg from a young donor. The theory — which remains unproven in rigorous clinical trials — is that the donor’s mitochondria might help the egg, once fertilized, or embryo to mature. Any resulting babies would have nuclear DNA from their biological mothers and fathers and mitochondrial DNA from the egg donor.
Scientists have already shown in a clinical trial that MRT can produce healthy children for parents whose mitochondria carry disease-causing mutations. But Nature has identified clinics in Asia, Europe and the Americas that advertise MRT to increase the success rate of in vitro fertilization (IVF) for a broader range of clients who do not have such mutations. “MRT can transform your fertility journey,” says the website of...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...